Literature DB >> 1471988

Alteration in proportions of histone H1 variants during the differentiation of murine erythroleukaemic cells.

W Helliger1, H Lindner, O Grübl-Knosp, B Puschendorf.   

Abstract

We have investigated the changes in the relative amounts of histone H1 zero and all five H1 variants during the differentiation in vitro of Friend erythroleukaemic cells. Three different agents were used as inducers of differentiation: dimethyl sulphoxide, hexamethylenebisacetamide and sodium butyrate. By applying a combination of reverse-phase h.p.l.c. and one-dimensional gel electrophoresis we observed that, during differentiation in vitro, (1) the relative amount of each subtype changes upon induction and that (2) dimethyl sulphoxide and hexamethylenebisacetamide produce a similar histone H1 pattern with a strong increase in histones H1 zero and H1c, a modest increase in histone H1e and a decrease in the relative amounts of histone H1a, H1b and H1d, whereas butyrate induces a different pattern, particularly with respect to both histones H1c and H1e: H1c increased slightly, and H1e strongly, during differentiation. These results are compared with changes in the histone H1 pattern during differentiation in vivo in the mouse [Lennox & Cohen (1983) J. Biol. Chem. 258, 262-268] and in the rat [Pina, Martinez & Suau (1987) Eur. J. Biochem. 164, 71-76], and similarities and deviations are discussed.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1471988      PMCID: PMC1131949          DOI: 10.1042/bj2880747

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  32 in total

1.  Differentiation in erythroleukemic cells and their somatic hybrids.

Authors:  S H Orkin; F I Harosi; P Leder
Journal:  Proc Natl Acad Sci U S A       Date:  1975-01       Impact factor: 11.205

2.  Histone acetylation alters the capacity of the H1 histones to condense transcriptionally active/competent chromatin.

Authors:  J A Ridsdale; M J Hendzel; G P Delcuve; J R Davie
Journal:  J Biol Chem       Date:  1990-03-25       Impact factor: 5.157

Review 3.  Erythroleukemic differentiation.

Authors:  P A Marks; R A Rifkind
Journal:  Annu Rev Biochem       Date:  1978       Impact factor: 23.643

4.  The histone H1 complements of dividing and nondividing cells of the mouse.

Authors:  R W Lennox; L H Cohen
Journal:  J Biol Chem       Date:  1983-01-10       Impact factor: 5.157

5.  Histone H10 accumulates in growth-inhibited cultured cells.

Authors:  J Pehrson; R D Cole
Journal:  Nature       Date:  1980-05-01       Impact factor: 49.962

6.  Cell volume changes in relation to the cell cycle of differentiating erythroleukemic cells.

Authors:  Y Gazitt; A D Deitch; P A Marks; R A Rifkind
Journal:  Exp Cell Res       Date:  1978-12       Impact factor: 3.905

7.  The H1 histones and their interphase phosphorylated states in differentiated and undifferentiated cell lines derived from murine teratocarcinomas.

Authors:  R W Lennox; R G Oshima; L H Cohen
Journal:  J Biol Chem       Date:  1982-05-10       Impact factor: 5.157

Review 8.  Reversible histone modifications and the chromosome cell cycle.

Authors:  E M Bradbury
Journal:  Bioessays       Date:  1992-01       Impact factor: 4.345

9.  Accumulation of histone H1(0) during chemically induced differentiation of murine neuroblastoma cells.

Authors:  C Pieler; G R Adolf; P Swetly
Journal:  Eur J Biochem       Date:  1981-04

10.  Involvement of histone H1 in the organization of the nucleosome and of the salt-dependent superstructures of chromatin.

Authors:  F Thoma; T Koller; A Klug
Journal:  J Cell Biol       Date:  1979-11       Impact factor: 10.539

View more
  9 in total

Review 1.  Role of H1 linker histones in mammalian development and stem cell differentiation.

Authors:  Chenyi Pan; Yuhong Fan
Journal:  Biochim Biophys Acta       Date:  2015-12-13

2.  Global modulation of chromatin dynamics mediated by dephosphorylation of linker histone H1 is necessary for erythroid differentiation.

Authors:  Dhananjay Yellajoshyula; David T Brown
Journal:  Proc Natl Acad Sci U S A       Date:  2006-11-21       Impact factor: 11.205

3.  Histone H1 variants are differentially expressed and incorporated into chromatin during differentiation and reprogramming to pluripotency.

Authors:  Jean-Michel Terme; Borja Sesé; Lluis Millán-Ariño; Regina Mayor; Juan Carlos Izpisúa Belmonte; María José Barrero; Albert Jordan
Journal:  J Biol Chem       Date:  2011-08-18       Impact factor: 5.157

4.  Mice develop normally without the H1(0) linker histone.

Authors:  A M Sirotkin; W Edelmann; G Cheng; A Klein-Szanto; R Kucherlapati; A I Skoultchi
Journal:  Proc Natl Acad Sci U S A       Date:  1995-07-03       Impact factor: 11.205

5.  A proposal for a coherent mammalian histone H1 nomenclature correlated with amino acid sequences.

Authors:  M H Parseghian; A H Henschen; K G Krieglstein; B A Hamkalo
Journal:  Protein Sci       Date:  1994-04       Impact factor: 6.725

6.  Human linker histones: interplay between phosphorylation and O-β-GlcNAc to mediate chromatin structural modifications.

Authors:  Waqar Ahmad; Khadija Shabbiri; Noreen Nazar; Shazia Nazar; Saba Qaiser; Mirza Abid Shabbir Mughal
Journal:  Cell Div       Date:  2011-07-12       Impact factor: 5.130

Review 7.  Histone H2A.Z deregulation in prostate cancer. Cause or effect?

Authors:  Deanna Dryhurst; Juan Ausió
Journal:  Cancer Metastasis Rev       Date:  2014-09       Impact factor: 9.264

Review 8.  H1.0 Linker Histone as an Epigenetic Regulator of Cell Proliferation and Differentiation.

Authors:  Carlo Maria Di Liegro; Gabriella Schiera; Italia Di Liegro
Journal:  Genes (Basel)       Date:  2018-06-20       Impact factor: 4.096

9.  Mapping of six somatic linker histone H1 variants in human breast cancer cells uncovers specific features of H1.2.

Authors:  Lluís Millán-Ariño; Abul B M M K Islam; Andrea Izquierdo-Bouldstridge; Regina Mayor; Jean-Michel Terme; Neus Luque; Mónica Sancho; Núria López-Bigas; Albert Jordan
Journal:  Nucleic Acids Res       Date:  2014-01-29       Impact factor: 16.971

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.